The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127393931 12739393 1 I 20140804 20160623 20160913 20160913 EXP JP-JNJFOC-20160625757 JANSSEN TOKUMOTO Y, WATANABE T, YOSHIDA O, HIROOKA M, M A, Y H. TREATMENT OUTCOME OF ANTIVIRAL THERAPY FOR RECURRENT CHRONIC HEPATITIS C AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE. 144 . 58.00 YR A M Y 0.00000 20160913 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127393931 12739393 1 PS SOVRIAD SIMEPREVIR 1 Oral N 205123 100 MG CAPSULE QD
127393931 12739393 2 SS PEGASYS PEGINTERFERON ALFA-2A 1 Subcutaneous 0 180 MG INJECTION /wk
127393931 12739393 3 SS COPEGUS RIBAVIRIN 1 Oral Y 0 1000 MG UNSPECIFIED QD
127393931 12739393 4 SS COPEGUS RIBAVIRIN 1 Oral Y 0 600 MG UNSPECIFIED QD
127393931 12739393 5 SS COPEGUS RIBAVIRIN 1 Oral Y 0 200 MG UNSPECIFIED QD
127393931 12739393 6 SS COPEGUS RIBAVIRIN 1 Oral Y 0 800 MG UNSPECIFIED QD
127393931 12739393 7 SS COPEGUS RIBAVIRIN 1 Oral Y 0 400 MG UNSPECIFIED QD
127393931 12739393 8 SS COPEGUS RIBAVIRIN 1 Oral Y 0 200 MG UNSPECIFIED QD
127393931 12739393 9 SS COPEGUS RIBAVIRIN 1 Oral Y 0 100 MG UNSPECIFIED QD
127393931 12739393 10 C FEBURIC FEBUXOSTAT 1 Oral 0 UNSPECIFIED
127393931 12739393 11 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
127393931 12739393 12 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 Unknown 0 UNSPECIFIED
127393931 12739393 13 C SENNA SENNA LEAFSENNOSIDESSENNOSIDES A AND B 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127393931 12739393 1 Antiviral treatment
127393931 12739393 2 Antiviral treatment
127393931 12739393 3 Antiviral treatment
127393931 12739393 4 Antiviral treatment
127393931 12739393 5 Antiviral treatment
127393931 12739393 6 Antiviral treatment
127393931 12739393 7 Antiviral treatment
127393931 12739393 8 Antiviral treatment
127393931 12739393 9 Antiviral treatment

Outcome of event

Event ID CASEID OUTC COD
127393931 12739393 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127393931 12739393 Anaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127393931 12739393 1 20140707 20140922 0
127393931 12739393 2 20140707 20141215 0
127393931 12739393 3 20140707 20140727 0
127393931 12739393 4 20141201 20141221 0
127393931 12739393 5 20141117 20141130 0
127393931 12739393 6 20140728 20140803 0
127393931 12739393 7 20140804 20140810 0
127393931 12739393 8 20140811 20140817 0
127393931 12739393 9 20140901 20141116 0